Sale!

PLA2G6 Gene PARK14 Parkinson Genetic Test

Original price was: $700.Current price is: $500.

-29%

The PLA2G6 Gene PARK14 Parkinson NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the PLA2G6 gene associated with PARK14 Parkinson’s disease. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect specific genetic variations that increase susceptibility to early-onset Parkinsonism and neurodegenerative conditions. The test provides crucial insights for individuals with family history of Parkinson’s disease, unexplained neurological symptoms, or those seeking proactive genetic screening. Results help guide personalized treatment approaches and inform family planning decisions. With a turnaround time of 3-4 weeks, this test requires blood, extracted DNA, or FTA card samples. The test is priced at $500 USD (discounted from $700 USD) and includes pre-test genetic counseling to ensure comprehensive understanding of results and implications.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

PLA2G6 Gene PARK14 Parkinson NGS Genetic DNA Test

Comprehensive Genetic Testing for Parkinson’s Disease Risk Assessment

The PLA2G6 Gene PARK14 Parkinson NGS Genetic DNA Test represents a breakthrough in neurological genetic testing, offering individuals and families unprecedented insights into their genetic predisposition to Parkinson’s disease. This advanced diagnostic tool specifically targets mutations in the PLA2G6 gene, which have been scientifically linked to PARK14 Parkinsonism – a distinct form of early-onset neurodegenerative disorder characterized by progressive motor symptoms and cognitive decline.

What Does This Test Measure?

This sophisticated genetic analysis utilizes Next-Generation Sequencing (NGS) technology to comprehensively examine the PLA2G6 gene for pathogenic variants associated with:

  • PARK14-linked Parkinsonism mutations
  • Autosomal recessive inheritance patterns
  • Specific genetic markers for early-onset Parkinson’s disease
  • Neurological degeneration risk factors
  • Genetic variations affecting phospholipase A2 enzyme function

Who Should Consider This Test?

This genetic screening is particularly recommended for individuals experiencing:

  • Early-onset Parkinson’s symptoms before age 50
  • Family history of Parkinson’s disease or related neurological disorders
  • Unexplained tremors, rigidity, or bradykinesia
  • Progressive neurological symptoms with unclear diagnosis
  • Planning for family and seeking genetic risk assessment
  • Diagnostic uncertainty in movement disorders

Clinical Benefits of Genetic Testing

Undergoing the PLA2G6 Gene PARK14 Parkinson NGS Genetic DNA Test provides numerous advantages:

  • Early Risk Identification: Detect genetic predisposition before symptom onset
  • Personalized Treatment Planning: Guide medication choices and therapeutic approaches
  • Family Planning Insights: Inform reproductive decisions and genetic counseling
  • Diagnostic Clarity: Resolve uncertain neurological diagnoses
  • Proactive Healthcare Management: Implement preventive strategies and monitoring
  • Research Contribution: Advance understanding of Parkinson’s genetics

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and neurologists:

  • Positive Result: Indicates presence of PLA2G6 gene mutation associated with increased Parkinson’s disease risk
  • Negative Result: No detected mutations in the analyzed gene regions
  • Variant of Uncertain Significance: Genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Identification of recessive gene mutations without disease manifestation

All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps for medical management.

Test Details and Pricing

Test Component Details
Test Name PLA2G6 Gene PARK14 Parkinson NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Methodology Next-Generation Sequencing (NGS) Technology
Specialty Neurology & Genetics

Pre-Test Requirements

Before scheduling your test, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session to discuss test implications
  • Family pedigree chart development
  • Understanding of potential results and their meanings
  • Discussion with your primary neurologist

Nationwide Accessibility

General Genetics Corporation maintains testing facilities across the United States, with convenient locations in:

  • New York City, NY
  • Los Angeles, CA
  • Chicago, IL
  • Houston, TX
  • Phoenix, AZ
  • Philadelphia, PA
  • San Antonio, TX
  • San Diego, CA
  • Dallas, TX
  • San Jose, CA

And all other major metropolitan areas throughout the country.

Take Control of Your Neurological Health Today

Don’t wait to gain critical insights into your genetic predisposition to Parkinson’s disease. Our comprehensive PLA2G6 Gene PARK14 Parkinson NGS Genetic DNA Test provides the scientific clarity you need for informed healthcare decisions.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward proactive neurological health management.

Our expert genetic counselors and neurologists are ready to guide you through the testing process, ensuring you receive the highest quality care and most accurate genetic insights available.